Heart failure (HF) 
Introduction
Chronic diseases are now considered the leading cause of morbidity and mortality worldwide. The progression of chronic end-stage organ failure, especially heart failure (HF), is typically marked by a gradual decline punctuated by acute deteriorations in health status and daily functioning. 1 The deterioration of organ failure can be life-threatening and increase the risk of hospital admission and need for intensive treatment. [1] [2] [3] HF is one of the principal causes of death in the world; the prevalence of this chronic disease in developed countries is from 1% to 2% of the adult population and approximately between 6% and 10% in the elderly. About 15 million people the world over and more than 4.9 million people in the United States suffer from HF, and the direct and indirect costs of the health care and treatment of these patients are very high. 1, 3 HF is progressive in nature; accordingly, treatment is mainly focused on slowing the progression of the disease and palliating the symptoms of the patients. 4, 5 Dyspnea and fatigue are deemed the hallmark symptoms of HF, and other symptoms such as pain are liable to go unnoticed. 6, 7 Nonetheless, awareness of the burden of pain and symptoms is growing in patients with HF. 8, 9 Pain in patients suffering from HF may be of different origins by different mechanisms such as ischemia, inflammation, and neuropathy. The experience of pain may diminish cognitive functioning and increase anxiety, sleeplessness, depression, and hopelessness. [10] [11] [12] Thus, it is highly beneficial to investigate the prevalence of pain and its source and management in patients with HF.
Methods
We undertook a comprehensive search using the MEDLINE database for studies and guidelines on the subject of pain and HF and the complications and considerations thereof. Our search comprised the MeSH headings of heart failure, cardiac failure, congestive heart failure, and heart decompensation, as well as pain and chest pain. We also sought additional articles by performing the same search strategy in the databases of EMBASE, ScienceDirect, and Google Scholar. Subsequently, we combined all the searches and removed the duplicates. The total number of potential articles in our primary search was 245 studies. We thereafter excluded irrelevant articles by reading their title and abstract and finally chose 65 studies for this review article.
Chronic Pain Syndrome in Chronic Diseases
Pain is one of the most common symptoms among individuals seeking medical attention and is identified as the chief complaint on presentation to the emergency department. [13] [14] [15] Patients tend to seek health care for pain not only for diagnostic evaluation and symptom relief but also for the interference of pain with personal performance and the resultant anxiety and emotional distress. When pain persists for weeks or months, the influence of the broader effects of pain on well-being becomes more palpable. Chronic pain can exert negative effects on psychological health and performance of social responsibilities in work and family life. 16 The major challenge in chronic pain is its unusual nature. In this syndrome, the etiology of pain is difficult to identify and the symptoms of pain do not usually respond to the common medical managements. Regardless of its etiology, the chronic pain syndrome affects many aspects of the patient's personal and medical life. The presence of the chronic pain syndrome in the setting of a chronic disease renders patients anxious, frustrated, and depressed-which may have deleterious effects on their therapies. 16 
Importance of Pain in Patients with Heart Failure
Patients with HF commonly experience pain in any part of their body. The pain is an important and frequent symptom, particularly during the time of exacerbation and hospitalization. 17 Much as pain has been recognized as the most common identifiable reason for clinical deterioration prior to admission to the hospital, the importance of pain in patients with HF is frequently underestimated by physicians. 18 It has been shown that patients with HF suffering from pain are older, enjoy lower levels of general health, have more comorbidities, and are even more likely to have a history of cancer than those without HF. 19 The experience of pain may weaken cognitive functioning and increase anxiety, sleeplessness, depression, and hopelessness. [10] [11] [12] Furthermore, the presence of pain, particularly when accompanied by fatigue and depression (common findings in HF), may lead to compromised functional performance. 20 Moreover, individuals experiencing depression and anxiety tend to have a lower rate of medication adherence, which is an essential component of self-management in patients with HF. 21 Pain may constitute an important symptom in patients with HF referring to the emergency department. It has been shown that the incidence rate of the acute coronary syndrome among patients with HF presenting to the emergency department with chest pain is 32%. These patients have more prolonged hospital stays, require higher levels of care, and have a higher incidence of death. Given the considerable importance of pain and its management in the setting of HF, we aimed to determine the prevalence of pain and evaluate its management and its impact on the quality of life of patients with HF.
Prevalence of Pain in Patients with Heart Failure
The prevalence of pain in HF varies between 23% and 85% in different studies (Table 1) . Although shortness of breath and fatigue are regarded as the most common symptoms of HF, there is a great deal of evidence indicating that pain is a significant symptom in patients with HF (Table 1) . [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] A remarkable number of studies show that the majority of patients with HF, particularly those with advanced HF, suffer from pain. 22, 23 Interestingly, patients with a lower left ventricular ejection fraction (LVEF) may have significantly higher pain scores than those with a higher LVEF. 24, 25 
Pathophysiology and Source of Pain in Heart Failure
Although the etiology of pain is clear in some instances such as trauma or surgery, the issue of pain in HF is controversial. Pain in chronic illnesses is multifactorial with physiological, sensory, sociocultural, affective, cognitive, and behavioral components. Nevertheless, in patients with HF, the causes of pain or altered pain perception have not been fully explained. Moreover, pain perception may vary from patient to patient and may be altered by other symptoms allied to HF such as shortness of breath, fatigue, depression, and anxiety. 34 J Teh Univ Heart Ctr 12 (2) http://jthc.tums.ac.ir April, 2017
Chronic Pain in Chronic Heart Failure: A Review Article Approximately 80% of patients with HF are elderly. 35 Multiple sources of pain such as physical, psychological, and neurological have been described in the elderly and they may be the sources of pain in HF. Increase in age has been defined as a marker of increase in pain levels among patients with HF in previous studies. 15, 32 Moreover, comorbid conditions such as cancers and other chronic illnesses increase by age. As a result, the presence of these conditions and the age-related increase in pain are frequently found in patients suffering from HF. The comorbidities presenting with HF that may be the source of pain in these patients include coronary artery disease, chronic obstructive pulmonary disease, cancers, depression, anxiety disorder, peripheral vascular disease, pneumonia, diabetes mellitus, osteoarthritis, and low back pain. 30 About one-third of patients with HF suffer from depression and the same proportion of them suffer from anxiety. A meta-analysis showed that major depression after HF was a predictor for subsequent all-cause mortality. Also, depressive mood in the wake of HF is a predictor of cardiovascular mortality. 36 There is a strong association between increasing depression and anxiety and greater levels of pain. Also, there is a correlation between dissatisfaction with pain control and level of pain, depression, and anxiety. 33 When death approaches, a significant trend toward an increase in anxiety and depression, as well as increasing rates of severe pain and dyspnea, is observed. 30 Table 2 presents the factors contributing to pain in patients with HF.
Cytokines and inflammatory markers may participate in the generation of pain or influence the central processing of pain stimuli. 37, 38 Gan et al. 26 evaluated the effects of serum levels of creatinine, NT-proBNP, high-sensitivity C-reactive protein, tumor necrosis factor-alpha (TNF-α), interleukin (IL)-6, and IL-10 on the symptoms of pain in patients with HF and found that only TNF-α levels were higher in those with pain. In the myocardium, the increased expression of TNF-α is associated with reversible and irreversible ischemia/reperfusion injury, post-myocardial infarction remodeling, fetal gene expression, myocyte hypertrophy or apoptosis, and altered endothelial and vascular smooth muscle cell function-contributing to the development and progression of HF. End-of-life HF is a painful condition influenced by various factors. The theory of "total pain" was defined by Dr. Cicely Saunders in 1984 to conceptualize pain at the end of life. 40 This theory can be extended to a chronic life-limiting, highly symptomatic disease such as advanced HF. Physical, emotional, social or interpersonal, and spiritual or existential facets contribute to the experience of "total pain". 41 Murray et al. 42 described the end-of-life trajectories of social, psychological, and spiritual needs associated with patients with end-stage HF during their last year of life. The authors reported that in advanced HF, the decline in social and psychological well-being runs in parallel with physical deterioration and that spiritual distress fluctuates more than J Teh Univ Heart Ctr 12 (2) http://jthc.tums.ac.ir April, 2017 other factors in advanced HF. Additionally, they concluded that spiritual distress is modulated by various other influences, including a perceived lack of understanding of these issues by health care professionals.
Physical pain is the most common form of pain. Chronic pain, which is frequent in HF, may be related to ongoing painful stimuli such as persistent inflammation or may be the result of the sensitization of central or peripheral neurons. 41 It is deserving of note that the symptoms of pain may be an indirect indicator of the severity of congestive HF. The source of pain among patients with HF has been discussed in previous studies. Pain may result from edema or from impaired circulation to organs due to congestion and low cardiac output. 34 Other sources of pain in HF include constipation, visceral ischemia, musculoskeletal fatigue, mucositis, and ascites-which need specific consideration and management. 29 Many patients with HF suffer from pain in different locations of the body-including head, chest, stomach, back, extremities, and joints. Chest pain is more prevalent in HF than in non-HF cardiac patients. 19 Udeoji et al. 25 found that 15% of their patients with stable chronic HF reported pain either in the chest, back, neck, and abdomen or in the extremities. About one-third of patients with HF experience chest pain. [1] [2] [3] The frequency of pain rises in patients with advanced HF. Goodlin et al. 22 reported that the frequency of pain in their patients with advanced HF was 85% and that 40% of their patients suffered from pain at more than 1 site. In their study, severe or very severe pain was observed in 29% of the subjects with chest pain and in 39% of those with other sites of pain. Based on evidence, the presence of chest pain in patients with HF can lead to worse outcomes. 4, 5 Letterman et al. 13 showed that chest pain in their series of patients with HF was associated with prolonged hospital stays, higher intensity care, and higher mortality. Moreover, results from the Carvedilol or Metoprolol European Trial (COMET) indicated that the presence of chest pain in patients with HF was significantly related to mortality and all-cause hospitalizations. 8 Another study noted acute chest pain as a precipitant for admission in patients with new-onset HF. 18 Interestingly, Goebel et al. 19 found that headaches were more frequent among their non-HF cardiac patients than among their patients with HF and postulated that it might have been in consequence of the widespread use of nitrates to control angina and optimize preload. Still, headache tolerance may be observed in patients with long-term nitrate use.
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Effect of Pain on Quality of Life in Patients with Heart Failure
Quality of life is a multidimensional subjective concept that is affected by many factors such as the physical, psychological, social, and economic status of patients and their symptoms and limitations in daily life activities. 54 Pain can act both as a direct and as an indirect factor affecting quality of life in patients with HF. 30 Some studies have shown that pain is an important factor preventing patients from doing their daily activities, which indirectly lowers their quality of life. 30 In addition, pain is a contributing factor to nonadherence to medication and treatment, which worsens the symptoms of these patients and their quality of life. 28 The direct impact of pain is its effect on the physical and psychological well-being of the patient; it is a salient factor in determining the quality of life in chronic diseases. 28 The experience of pain also lessens cognitive functioning and increases anxiety, sleeplessness, depression, and hopelessness-thereby diminishing quality of life in these patients.
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Management of Pain in Patients with Heart Failure
The first step in managing pain in patients with HF is to identify the location, severity, and frequency of the pain as well as its possible causes and association with other problems. 42 Pain from different sources should be treated by resolving the causative mechanism such as constipation, mucositis, and ascites. 43, 44 As curative care options are limited for chronic pain caused by mechanisms unknown or not curable, palliation has become the priority in these patients. 45, 46 Successful chronic pain management is defined as providing adequate analgesia without excessive adverse effects. 47 There have been different pharmaceutical therapies for treating pain in chronic diseases such as non-opioids like nonsteroidal anti-inflammatory (NSAID) drugs and opioids like codeine, morphine, and tramadol. Cardiovascular risks associated with the use of NSAIDs are important. NSAIDs, particularly cyclooxygenase 2 (COX-2) selective agents, have been reported to increase the risk of thrombotic events and myocardial infarction in patients with coronary artery disease and atherosclerosis. This led the American Heart Association to recommend that acetaminophen or nonacetylated salicylates be prescribed for patients with coronary artery disease. 48, 49 The suitability of opioids for chronic noncancer pain treatment is under debate. The efficacy of opioids in this clinical situation has only been reported in short-term trials, and evidence for their overall benefit in long-term therapy is missing. 50 Other drugs used in the treatment of chronic pain are antidepressants and anticonvulsants. The exact mechanism whereby antidepressants alleviate pain is not completely understood, but it is believed that they mediate the effect by inhibiting the neurotransmitter reuptake in the synaptic cleft. 51 The safety of these drugs in patients with HF has yet to be fully investigated. 51 Cannabinoids and triptans, which are also used for the management of chronic pain, are not safe in patients with coronary artery disease, J Teh Univ Heart Ctr 12 (2) http://jthc.tums.ac.ir April, 2017 uncontrolled hypertension, and arrhythmias. 52, 53 Because of the multiple interactions and adverse effects of these drugs in the management of chronic pain, there have been efforts to find novel ways for alleviating pain in these patients. 47 One of the novel methods for treating chronic pain is gene therapy, which utilizes viral vectors containing viral genome replaced with nucleic acid sequences encoding a promoter to drive gene expression as well as a transgene of interest such as an analgesic agent. A recent study in patients with terminal cancer demonstrated proof-of-concept for gene therapy in pain management. Physical training and exercise has been shown to significantly decrease circulating proinflammatory cytokines such as TNF-α and IL-6 and their soluble receptors (i.e., TNF-RI, TNF-RII, and IL-6R). These beneficial effects may be related to the training-induced improvement in the functional status of patients with HFsuggesting that persistent immune activation appears to be involved in impaired exercise capacity, which characterizes this syndrome. 54, 55 As the different cytokines addressed in these studies play a role in generating pain in patients with HF, 33 it may be concluded that physical training and exercise can be of great help in alleviating pain in these patients. Other alternative self-treatments that can be employed by patients suffering from HF include walking, stretching, and using heat and cold on the zone of pain-which have yet to be comprehensively studied.
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Conclusion
Although chronic pain is a common symptom in patients with HF and has a remarkable impact on various aspects of the management modalities of these patients, optimal control of pain is impossible. Further investigations are needed to find a safe and efficacious way for controlling pain in patients with HF.
